首頁 > 市場調查報告書 > 製藥

個人化醫學

市場調查報告書

商品編碼

1905168

日本精準醫療市場報告（按產品、技術、應用（腫瘤學、中樞神經系統、免疫學、呼吸系統醫學、感染及其他）、最終用戶和地區分類，2026-2034）

Japan Precision Medicine Market Report by Product, Technology, Application (Oncology, Central Nervous System, Immunology, Respiratory Medicine, Infections, and Others), End User, and Region 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 118 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2025年，日本精準醫療市場規模達50.88億美元。展望未來， IMARC Group預計到2034年，該市場規模將達到76.005億美元，2026年至2034年間的複合年成長率（CAGR）為4.56%。推動市場成長的主要因素是遠距醫療和遠距監測技術需求的不斷成長，這些技術能夠持續收集和分析資料，從而使醫療服務提供者能夠根據個別患者資料即時調整治療方案。

本報告解答的關鍵問題：

日本精準醫療市場目前表現如何？未來幾年又將如何發展？
新冠疫情對日本精準醫療市場產生了哪些影響？
日本精準醫療市場的產品組成是怎樣的？
日本精準醫療市場依技術分類的組成是怎樣的？
日本精準醫療市場依應用領域分類的組成是怎樣的？
日本精準醫療市場依最終用戶分類的組成是怎樣的？
日本精準醫療市場價值鏈的各個階段有哪些？
日本精準醫療的關鍵促進因素和挑戰是什麼？
日本精準醫療市場的結構是怎麼樣的？主要參與者有哪些？
日本精準醫療市場的競爭程度如何？

Japan precision medicine market size reached USD 5,088.0 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 7,600.5 Million by 2034, exhibiting a growth rate (CAGR) of 4.56% during 2026-2034. The increasing demand for telemedicine and remote monitoring technologies, which allow for continuous data collection and analysis, thereby enabling healthcare providers to make real-time adjustments to treatment plans based on individual patient data, is primarily driving the market.

Precision medicine refers to an innovative healthcare approach that tailors medical treatment and interventions to individual patients based on their unique environmental, genetic, and lifestyle factors. Unlike traditional one-size-fits-all approaches, precision medicine recognizes that each person's genetic makeup and life circumstances are distinct. By analyzing a person's genetic profile and other relevant data, healthcare providers can make more accurate diagnoses, predict disease risk, and personalize treatment plans. This approach allows for treatments that are not only more effective but also potentially safer, as they minimize adverse effects. Precision medicine has shown promising results in various medical fields, such as oncology, where targeted therapies can be designed to specifically combat cancer cells while sparing healthy tissue. It also has applications in areas like cardiology, neurology, and psychiatry, helping to optimize treatments for ailments ranging from heart disease to mental health disorders. Ultimately, precision medicine aims to revolutionize healthcare by delivering tailored, efficient, and patient-centered solutions that improve outcomes and quality of life.

Japan Precision Medicine Market Trends:

The precision medicine in Japan is rapidly gaining momentum in the healthcare industry. Several drivers are propelling its growth. Firstly, advancements in genomics and biotechnology have paved the way for a deeper understanding of the genetic basis of diseases. This knowledge has enabled the development of targeted therapies, leading to improved patient outcomes. Moreover, the increasing incidence of chronic diseases in Japan is a significant driver. Precision medicine offers the promise of more efficacious treatments and better disease management, potentially reducing the burden on healthcare systems. Additionally, government initiatives and funding support for precision medicine R&D are playing a pivotal role. Policymakers recognize the potential of precision medicine to reduce healthcare costs and improve patient care, leading to increased investments in this field. Apart from this, the inflating application of big data and advanced analytics tools with the integration of electronic health records, genomic data, and clinical information that allow for more precise diagnosis and treatment recommendations is expected to drive the precision medicine in Japan during the forecast period.

Japan Precision Medicine Market Segmentation:

Product Insights:

Consumables
Instruments
Services

Technology Insights:

Big Data Analytics
Bioinformatics
Gene Sequencing
Drug Discovery
Companion Diagnostics
Others

Application Insights:

Oncology
Central Nervous System (CNS)
Immunology
Respiratory Medicine
Infections
Others

End User Insights:

Hospitals and Clinics
Diagnostic Centers
Pharma and Biotech Companies
Healthcare IT Firms
Others

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan precision medicine market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan precision medicine market?
What is the breakup of the Japan precision medicine market on the basis of product?
What is the breakup of the Japan precision medicine market on the basis of technology?
What is the breakup of the Japan precision medicine market on the basis of application?
What is the breakup of the Japan precision medicine market on the basis of end user?
What are the various stages in the value chain of the Japan precision medicine market?
What are the key driving factors and challenges in the Japan precision medicine?
What is the structure of the Japan precision medicine market and who are the key players?
What is the degree of competition in the Japan precision medicine market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Precision Medicine Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Precision Medicine Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Precision Medicine Market - Breakup by Product

6.1 Consumables
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Instruments
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)
6.3 Services
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2020-2025)
- 6.3.3 Market Forecast (2026-2034)

7 Japan Precision Medicine Market - Breakup by Technology

7.1 Big Data Analytics
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Bioinformatics
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)
7.3 Gene Sequencing
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2020-2025)
- 7.3.3 Market Forecast (2026-2034)
7.4 Drug Discovery
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2020-2025)
- 7.4.3 Market Forecast (2026-2034)
7.5 Companion Diagnostics
- 7.5.1 Overview
- 7.5.2 Historical and Current Market Trends (2020-2025)
- 7.5.3 Market Forecast (2026-2034)
7.6 Others
- 7.6.1 Historical and Current Market Trends (2020-2025)
- 7.6.2 Market Forecast (2026-2034)

8 Japan Precision Medicine Market - Breakup by Application

8.1 Oncology
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 Central Nervous System (CNS)
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)
8.3 Immunology
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Forecast (2026-2034)
8.4 Respiratory Medicine
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2020-2025)
- 8.4.3 Market Forecast (2026-2034)
8.5 Infections
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2020-2025)
- 8.5.3 Market Forecast (2026-2034)
8.6 Others
- 8.6.1 Historical and Current Market Trends (2020-2025)
- 9.6.2 Market Forecast (2026-2034)

9 Japan Precision Medicine Market - Breakup by End User

9.1 Hospitals and Clinics
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Forecast (2026-2034)
9.2 Diagnostic Centers
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Forecast (2026-2034)
9.3 Pharma and Biotech Companies
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2020-2025)
- 9.3.3 Market Forecast (2026-2034)
9.4 Healthcare IT Firms
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2020-2025)
- 9.4.3 Market Forecast (2026-2034)
9.5 Others
- 9.5.1 Historical and Current Market Trends (2020-2025)
- 9.5.2 Market Forecast (2026-2034)

10 Japan Precision Medicine Market - Breakup by Region

10.1 Kanto Region
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2020-2025)
- 10.1.3 Market Breakup by Product
- 10.1.4 Market Breakup by Technology
- 10.1.5 Market Breakup by Application
- 10.1.6 Market Breakup by End User
- 10.1.7 Key Players
- 10.1.10 Market Forecast (2026-2034)
10.2 Kansai/Kinki Region
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2020-2025)
- 10.2.3 Market Breakup by Product
- 10.2.4 Market Breakup by Technology
- 10.2.5 Market Breakup by Application
- 10.2.6 Market Breakup by End User
- 10.2.7 Key Players
- 10.2.8 Market Forecast (2026-2034)
10.3 Central/ Chubu Region
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2020-2025)
- 10.3.3 Market Breakup by Product
- 10.3.4 Market Breakup by Technology
- 10.3.5 Market Breakup by Application
- 10.3.6 Market Breakup by End User
- 10.3.7 Key Players
- 10.3.8 Market Forecast (2026-2034)
10.4 Kyushu-Okinawa Region
- 10.4.1 Overview
- 10.4.2 Historical and Current Market Trends (2020-2025)
- 10.4.3 Market Breakup by Product
- 10.4.4 Market Breakup by Technology
- 10.4.5 Market Breakup by Application
- 10.4.6 Market Breakup by End User
- 10.4.7 Key Players
- 10.4.8 Market Forecast (2026-2034)
10.5 Tohoku Region
- 10.5.1 Overview
- 10.5.2 Historical and Current Market Trends (2020-2025)
- 10.5.3 Market Breakup by Product
- 10.5.4 Market Breakup by Technology
- 10.5.5 Market Breakup by Application
- 10.5.6 Market Breakup by End User
- 10.5.7 Key Players
- 10.5.8 Market Forecast (2026-2034)
10.6 Chugoku Region
- 10.6.1 Overview
- 10.6.2 Historical and Current Market Trends (2020-2025)
- 10.6.3 Market Breakup by Product
- 10.6.4 Market Breakup by Technology
- 10.6.5 Market Breakup by Application
- 10.6.6 Market Breakup by End User
- 10.6.7 Key Players
- 10.6.8 Market Forecast (2026-2034)
10.7 Hokkaido Region
- 10.7.1 Overview
- 10.7.2 Historical and Current Market Trends (2020-2025)
- 10.7.3 Market Breakup by Product
- 10.7.4 Market Breakup by Technology
- 10.7.5 Market Breakup by Application
- 10.7.6 Market Breakup by End User
- 10.7.7 Key Players
- 10.7.8 Market Forecast (2026-2034)
10.8 Shikoku Region
- 10.8.1 Overview
- 10.8.2 Historical and Current Market Trends (2020-2025)
- 10.8.3 Market Breakup by Product
- 10.8.4 Market Breakup by Technology
- 10.8.5 Market Breakup by Application
- 10.8.6 Market Breakup by End User
- 10.8.7 Key Players
- 10.8.8 Market Forecast (2026-2034)

11 Japan Precision Medicine Market - Competitive Landscape

11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant

12 Profiles of Key Players

12.1 Company A
- 12.1.1 Business Overview
- 12.1.2 Product Portfolio
- 12.1.3 Business Strategies
- 12.1.4 SWOT Analysis
- 12.1.5 Major News and Events
12.2 Company B
- 12.2.1 Business Overview
- 12.2.2 Product Portfolio
- 12.2.3 Business Strategies
- 12.2.4 SWOT Analysis
- 12.2.5 Major News and Events
12.3 Company C
- 12.3.1 Business Overview
- 12.3.2 Product Portfolio
- 12.3.3 Business Strategies
- 12.3.4 SWOT Analysis
- 12.3.5 Major News and Events
12.4 Company D
- 12.4.1 Business Overview
- 12.4.2 Product Portfolio
- 12.4.3 Business Strategies
- 12.4.4 SWOT Analysis
- 12.4.5 Major News and Events
12.5 Company E
- 12.5.1 Business Overview
- 12.5.2 Product Portfolio
- 12.5.3 Business Strategies
- 12.5.4 SWOT Analysis
- 12.5.5 Major News and Events

13 Japan Precision Medicine Market - Industry Analysis

13.1 Drivers, Restraints, and Opportunities
- 13.1.1 Overview
- 13.1.2 Drivers
- 13.1.3 Restraints
- 13.1.4 Opportunities
13.2 Porters Five Forces Analysis
- 13.2.1 Overview
- 13.2.2 Bargaining Power of Buyers
- 13.2.3 Bargaining Power of Suppliers
- 13.2.4 Degree of Competition
- 13.2.5 Threat of New Entrants
- 13.2.6 Threat of Substitutes
13.3 Value Chain Analysis